Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PSNC stresses need of further work on contractor representation recommendations

The PSNC has said that a detailed further analysis is required to explore the benefits, practicalities, and potential consequences of the 33 recommendations on pharmacy contractor representation.

The pharmacy body in its statement last week also emphasized the need of the formation of a cross sector group to lead the work on those recommendations.


The recommendations are part of a report by the independent review into contractor support and representation.

The review, which the PSNC has initiated in 2019 working together with the Local Pharmaceutical Committees (LPCs), concluded in summer 2020 with the publication of the report on the future working of the PSNC and LPCs.

The further work on the recommendations will need some upfront, seed funding to ensure that the right people are engaged and that professional help can be paid for to support any cross-sector group leading the work, the PSNC has opined.

“Once the shape of any such group, and its remit, have been established, PSNC believes the next steps should be co-funded by the PSNC and the LPCs (recognising that all of this is, ultimately, contractors’ money), possibly from any savings on travel and meeting costs made in 2020.

“PSNC is not yet taking a view on long term funding, as that will depend on the findings of the next stage of the review process. However, its view is that contractors should not be asked for any more money, and that there should be consistency in what levies contractors pay and what they get in return for that.”

The PSNC said the cross-sector group, with an independent chair, should be representative of all contractors, LPCs and the PSNC, with a strong focus on contractors.

Meanwhile, the PSNC is concerned that, as with any change process in any sector, there is the potential for discussions about change to become divisive: the outcome of the independent review must not be to increase divisions in the community pharmacy sector.

“PSNC recognises that hearing views from the large number of contractors will be a challenge and this will be an important job for the next stages of this process: we welcome attempts by others to start those conversations already,” the pharmacy body has said.

“While this will undoubtedly lead to some challenging conversations and decisions in the coming months, we look forward to working together towards changes that will benefit all community pharmacy contractors,” the PSNC concluded.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less